HCRT and narcolepsy: Orexin receptor agonists are being researched as potential new therapies for narcolepsy [1] as recent research indicates that the loss of lateral hypothalamic neurons, which produce the neurotransmitter hypocretin, is the primary pathophysiology of human narcolepsy.